Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.1M Buy
310,300
+285,700
+1,161% +$34.6M 0.05% 306
2026
Q1
$4.02M Sell
24,600
-43,400
-64% -$6.67M 0.01% 1311
2025
Q4
$11.8M Sell
68,000
-8,000
-11% -$1.46M 0.02% 638
2025
Q3
$10.9M Buy
76,000
+62,400
+459% +$7.64M 0.02% 731
2025
Q2
$1.37M Buy
13,600
+5,600
+70% +$428K ﹤0.01% 1930
2025
Q1
$610K Sell
8,000
-2,200
-22% -$168K ﹤0.01% 2153
2024
Q4
$704K Hold
10,200
﹤0.01% 1987
2024
Q3
$745K Buy
+10,200
New +$753K ﹤0.01% 1797

Other funds holding INSM

Paul Tudor Jones's INSM Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Insmed (INSM) in Q2 2026: 195,391 shares worth $20.8M. The stake represents 0.03% of the portfolio and ranks #467 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in INSM as recently as Q3 2025.

Paul Tudor Jones first reported a position in INSM in Q1 2015 and has held it in 28 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Paul Tudor Jones held 195,391 shares of Insmed worth $20.8M as of Q2 2026.
  • Insmed was a new Paul Tudor Jones position in Q2 2026.
  • Insmed made up 0.03% of Paul Tudor Jones's portfolio in Q2 2026, its #467 holding.
  • Paul Tudor Jones first reported a position in Insmed in Q1 2015 and has held it in 28 quarters since.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.